USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows

Markets GlobeNewswire By GlobeNewswire 09 Nov 2026 14:21 1 min read
USARAD, a Nanox Company, Expands Collaboration with AZmed to Integrate FDA-Cleared X-ray AI into Its Teleradiology Workflows

PETACH TIKVA, Israel, Nov. 9, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (“Nanox” or the “Company”, NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced that its wholly owned subsidiary, USARAD Holdings, Inc. (“USARAD”), is expanding its existing collaboration with AZmed, a medical imaging AI company specializing in AI-powered X-ray analysis, to further integrate AZmed’s X-ray AI solutions into USARAD’s radiology workflows through Nanox Marketplace.

Covered in this story

Call it yourself

No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on NOV →

Dalsna Finance is currently tracking 103 stories mentioning NOV, the earliest published 7 Oct 2025.

Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.